These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


97 related items for PubMed ID: 4295835

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of reserpine and other drugs on the monoamine metabolism with special reference to the CNS.
    Andén NE.
    Ann Med Exp Biol Fenn; 1968; 46(3):361-6. PubMed ID: 4308996
    [No Abstract] [Full Text] [Related]

  • 3. Effects of drugs on inhibitory synapses.
    Krnjević K.
    Adv Cytopharmacol; 1971 May; 1():419-26. PubMed ID: 4356765
    [No Abstract] [Full Text] [Related]

  • 4. [Central effects of betamezide].
    Mikhaĭlova TV, Gilev AP, Khavronina-Gureeva ZP.
    Farmakol Toksikol; 1969 May; 32(6):652-6. PubMed ID: 5381593
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. How important is the synthesis of brain 5-hydroxytryptamine in the physiological control of its central function?
    Grahame-Smith DG.
    Adv Biochem Psychopharmacol; 1974 May; 10():83-91. PubMed ID: 4367772
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The role of monoamine oxidase and catechol O-methyltransferase in dopaminergic neurotransmission.
    Napolitano A, Cesura AM, Da Prada M.
    J Neural Transm Suppl; 1995 May; 45():35-45. PubMed ID: 8748607
    [Abstract] [Full Text] [Related]

  • 11. Central nervous system effects of fenfluramine hydrochloride.
    Ziance RJ, Sipes IG, Kinnard WJ, Buckley JP.
    J Pharmacol Exp Ther; 1972 Jan; 180(1):110-7. PubMed ID: 5062254
    [No Abstract] [Full Text] [Related]

  • 12. [Proceedings: Role of CNS in radiation-protective effect of 5-hydroxytryptamine in mice].
    Streffer C, Konermann G.
    Z Klin Chem Klin Biochem; 1972 Apr; 10(4):181. PubMed ID: 4681019
    [No Abstract] [Full Text] [Related]

  • 13. Rapid effects of monoamine oxidase inhibitors on synthesis and release of central monoamines.
    Glowinski J, Hamon M, Javoy F, Morot-Gaudry Y.
    Adv Biochem Psychopharmacol; 1972 Apr; 5():423-39. PubMed ID: 4403372
    [No Abstract] [Full Text] [Related]

  • 14. Serotonin syndrome.
    Ivanusa Z, Hećimović H, Demarin V.
    Neuropsychiatry Neuropsychol Behav Neurol; 1997 Jul; 10(3):209-12. PubMed ID: 9297715
    [Abstract] [Full Text] [Related]

  • 15. Potentiation and antagonism of biogenic amines.
    Rauzzino FJ, Seifter J.
    J Pharmacol Exp Ther; 1967 Jul; 157(1):143-8. PubMed ID: 5298351
    [No Abstract] [Full Text] [Related]

  • 16. A comparison of the effects of some monoamine oxidase (MAO) inhibitors with 5-hydroxytryptophan (5-HTP) and dihydroxyphenylalanine (DOPA) on spinal synaptic activity.
    Anderson EG, Baker R, Banna N.
    Proc West Pharmacol Soc; 1966 Jul; 9():40-1. PubMed ID: 5958499
    [No Abstract] [Full Text] [Related]

  • 17. Comparative aspects of selected psychoactive compounds: biogenic amines, monoamine oxidase inhibitors, and lysergic acid diethylamide.
    Pscheidt GR.
    Comp Biochem Physiol; 1968 Jan; 24(1):249-65. PubMed ID: 4868883
    [No Abstract] [Full Text] [Related]

  • 18. 2'-NH2-MPTP in Swiss Webster mice: evidence for long-term (6-month) depletions in cortical and hippocampal serotonin and norepinephrine, differential protection by selective uptake inhibitors or clorgyline and functional changes in central serotonin neurotransmission.
    Andrews AM, Murphy DL.
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1432-9. PubMed ID: 8263805
    [Abstract] [Full Text] [Related]

  • 19. The effects of monoamine oxidase inhibitors on spinal synaptic activity.
    Anderson EG, Baker RG, Banna NR.
    J Pharmacol Exp Ther; 1967 Dec; 158(3):405-15. PubMed ID: 5299660
    [No Abstract] [Full Text] [Related]

  • 20. [Biochemical pharmacology of the central nervous system. 6. Specific inhibitors of enzymes implied in the synthesis of cerebral serotonin].
    Corgier M, Pacheco H.
    Therapie; 1973 Dec; 28(4):639-49. PubMed ID: 4793684
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.